FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056555599> ?p ?o ?g. }

• W2056555599 endingPage "83" @default.
• W2056555599 startingPage "78" @default.
• W2056555599 abstract "Phenylketonuria (PKU) is an autosomal recessive disorder caused by deficiency of hepatic phenylalanine hydroxylase (PAH) leading to increased levels of phenylalanine in the plasma. Phenylalanine levels and phenylalanine hydroxylase (PAH) activity monitoring are currently limited to conventional blood dot testing. 1-(13)C-phenylalanine, a stable isotope can be used to examine phenylalanine metabolism, as the conversion of phenylalanine to tyrosine occurs in vivo via PAH and subsequently releases the carboxyl labeled (13)C as (13)CO2 in breath.Our objective was to examine phenylalanine metabolism in children with PKU using a minimally-invasive 1-(13)C-phenylalanine breath test ((13)C-PBT).Nine children (7 M: 2 F, mean age 12.5 ± 2.87 y) with PKU participated in the study twice: once before and once after sapropterin supplementation. Children were provided 6 mg/kg oral dose of 1-(13)C-phenylalanine and breath samples were collected at 20 min intervals for a period of 2h. Rate of CO2 production was measured at 60 min post-oral dose using indirect calorimetry. The percentage of 1-(13)C-phenylalanine exhaled as (13)CO2 was measured over a 2h period. Prior to studying children with PKU, we tested the study protocol in healthy children (n = 6; 4M: 2F, mean age 10.2 ± 2.48 y) as proof of principle.Production of a peak enrichment (Cmax) of (13)CO2 (% of dose) in all healthy children occurred at 20 min ranging from 17-29% of dose, with a subsequent return to ~5% by the end of 2h. Production of (13)CO2 from 1-(13)C-phenylalanine in all children with PKU prior to sapropterin treatment remained low. Following sapropterin supplementation for a week, production of (13)CO2 significantly increased in five children with a subsequent decline in blood phenylalanine levels, suggesting improved PAH activity. Sapropterin treatment was not effective in three children whose (13)CO2 production remained unchanged, and did not show a reduction in blood phenylalanine levels and improvement in dietary phenylalanine tolerance.Our study shows that the (13)C-PBT can be a minimally invasive, safe and reliable measure to examine phenylalanine metabolism in children with phenylketonuria. The breath data are corroborated by blood phenylalanine levels in children who had increased responses in (13)CO2 production, as reviewed post-hoc from clinical charts." @default.
• W2056555599 created "2016-06-24" @default.
• W2056555599 creator A5005499388 @default.
• W2056555599 creator A5015022653 @default.
• W2056555599 creator A5029685538 @default.
• W2056555599 creator A5030628704 @default.
• W2056555599 creator A5050254182 @default.
• W2056555599 creator A5053271368 @default.
• W2056555599 creator A5054534850 @default.
• W2056555599 date "2015-06-01" @default.
• W2056555599 modified "2023-09-25" @default.
• W2056555599 title "Minimally invasive 13C-breath test to examine phenylalanine metabolism in children with phenylketonuria" @default.
• W2056555599 cites W1973236187 @default.
• W2056555599 cites W1986731014 @default.
• W2056555599 cites W1990591430 @default.
• W2056555599 cites W2003183768 @default.
• W2056555599 cites W2006724685 @default.
• W2056555599 cites W2010407297 @default.
• W2056555599 cites W2013225052 @default.
• W2056555599 cites W2019843119 @default.
• W2056555599 cites W2020086513 @default.
• W2056555599 cites W2024820843 @default.
• W2056555599 cites W2026935730 @default.
• W2056555599 cites W2036387910 @default.
• W2056555599 cites W2037047569 @default.
• W2056555599 cites W2053681056 @default.
• W2056555599 cites W2054736648 @default.
• W2056555599 cites W2055174800 @default.
• W2056555599 cites W2055432116 @default.
• W2056555599 cites W2067570006 @default.
• W2056555599 cites W2076812105 @default.
• W2056555599 cites W2078378661 @default.
• W2056555599 cites W2089659821 @default.
• W2056555599 cites W2094140621 @default.
• W2056555599 cites W2094784564 @default.
• W2056555599 cites W2123725204 @default.
• W2056555599 cites W2135749829 @default.
• W2056555599 cites W2168138547 @default.
• W2056555599 cites W2171392078 @default.
• W2056555599 cites W4249791806 @default.
• W2056555599 doi "https://doi.org/10.1016/j.ymgme.2015.04.005" @default.
• W2056555599 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25943030" @default.
• W2056555599 hasPublicationYear "2015" @default.
• W2056555599 type Work @default.
• W2056555599 sameAs 2056555599 @default.
• W2056555599 citedByCount "6" @default.
• W2056555599 countsByYear W20565555992016 @default.
• W2056555599 countsByYear W20565555992017 @default.
• W2056555599 countsByYear W20565555992020 @default.
• W2056555599 countsByYear W20565555992021 @default.
• W2056555599 countsByYear W20565555992022 @default.
• W2056555599 crossrefType "journal-article" @default.
• W2056555599 hasAuthorship W2056555599A5005499388 @default.
• W2056555599 hasAuthorship W2056555599A5015022653 @default.
• W2056555599 hasAuthorship W2056555599A5029685538 @default.
• W2056555599 hasAuthorship W2056555599A5030628704 @default.
• W2056555599 hasAuthorship W2056555599A5050254182 @default.
• W2056555599 hasAuthorship W2056555599A5053271368 @default.
• W2056555599 hasAuthorship W2056555599A5054534850 @default.
• W2056555599 hasConcept C126322002 @default.
• W2056555599 hasConcept C134018914 @default.
• W2056555599 hasConcept C185592680 @default.
• W2056555599 hasConcept C207009774 @default.
• W2056555599 hasConcept C22979827 @default.
• W2056555599 hasConcept C2775981797 @default.
• W2056555599 hasConcept C2776165026 @default.
• W2056555599 hasConcept C2776409635 @default.
• W2056555599 hasConcept C2777431362 @default.
• W2056555599 hasConcept C3020079912 @default.
• W2056555599 hasConcept C515207424 @default.
• W2056555599 hasConcept C55493867 @default.
• W2056555599 hasConcept C62231903 @default.
• W2056555599 hasConcept C71924100 @default.
• W2056555599 hasConceptScore W2056555599C126322002 @default.
• W2056555599 hasConceptScore W2056555599C134018914 @default.
• W2056555599 hasConceptScore W2056555599C185592680 @default.
• W2056555599 hasConceptScore W2056555599C207009774 @default.
• W2056555599 hasConceptScore W2056555599C22979827 @default.
• W2056555599 hasConceptScore W2056555599C2775981797 @default.
• W2056555599 hasConceptScore W2056555599C2776165026 @default.
• W2056555599 hasConceptScore W2056555599C2776409635 @default.
• W2056555599 hasConceptScore W2056555599C2777431362 @default.
• W2056555599 hasConceptScore W2056555599C3020079912 @default.
• W2056555599 hasConceptScore W2056555599C515207424 @default.
• W2056555599 hasConceptScore W2056555599C55493867 @default.
• W2056555599 hasConceptScore W2056555599C62231903 @default.
• W2056555599 hasConceptScore W2056555599C71924100 @default.
• W2056555599 hasIssue "2-3" @default.
• W2056555599 hasLocation W20565555991 @default.
• W2056555599 hasLocation W20565555992 @default.
• W2056555599 hasOpenAccess W2056555599 @default.
• W2056555599 hasPrimaryLocation W20565555991 @default.
• W2056555599 hasRelatedWork W1876798024 @default.
• W2056555599 hasRelatedWork W1991882004 @default.
• W2056555599 hasRelatedWork W1994481004 @default.
• W2056555599 hasRelatedWork W2054293840 @default.
• W2056555599 hasRelatedWork W2104304590 @default.
• W2056555599 hasRelatedWork W2313260943 @default.

• next